Interview: Korea's Enzychem Eyes Global Expansion Via Nature-Inspired Drug
Executive Summary
Enzychem Lifesciences Chairman and CEO Ki Young Sohn tells Scrip how the Korean biotech is evolving from a functional health food maker into a global biopharma company, using its first-in-class, proprietary immune modulator platform technology EC-18, derived from a long-known traditional medicine antler extract.